Asset Details
Do you wish to reserve the book?
The optimal timing of breast cancer surgery after COVID-19 infection: an observational study
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The optimal timing of breast cancer surgery after COVID-19 infection: an observational study
Do you wish to request the book?
The optimal timing of breast cancer surgery after COVID-19 infection: an observational study
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The optimal timing of breast cancer surgery after COVID-19 infection: an observational study
2024
Overview
Purpose
It is controversial for the optimal time of breast cancer surgery after COVID-19 infection. Purpose was to assess the risk of postoperative complication in breast cancer patients with COVID-19 infection, in order to select optimal surgery timing after COVID-19 infection.
Methods
Breast cancer patients infected with COVID-19 and performed surgery between December 20th, 2022 to March 20th, 2023 were included in this prospective study (
n
= 577). Patients performed surgery between May 1, 2019 to October 1, 2019 were listed as control group (
n
= 329). They had not been infected with COVID-19 before surgery. Patients were grouped by time of surgery relative to COVID-19 infection. Database was evaluated using logistic regression.
Results
Patients infected with COVID-19 had a higher incidence of complications after surgery compared to that not-COVID-19 infection (6.59% vs. 3.04%). Multivariable logistic analysis demonstrated that timing of surgery was associated with complications (OR = 4.253; 95% CI: 0.855–21.153,
P =
0.044). Patients performed surgery within 2 weeks after COVID-19 infection had the highest rates of complication (17.65%) when compared with other groups, while the incidence was decreased into 5.51% when surgery 2 weeks or more after COVID-19 infection. With a median follow-up was 10 months, all patients with complications were recovered without serious complications or death, which had no adverse effect on subsequent anti-tumor therapy.
Conclusions
It needs to be cautious when breast cancer surgery was performed within 2 weeks after COVID-19 infection. Although the incidence of complications in patients undergoing surgery 2 weeks after COVID-19 infection is still slightly high, surgery might be recommended considering urgency of treatment, good prognosis of complications and the lack of influence on subsequent adjuvant therapy.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Aged
/ Biomedical and Life Sciences
/ Breast Neoplasms - complications
/ Cancer
/ Complications and side effects
/ COVID-19
/ Female
/ Fever
/ Health Promotion and Disease Prevention
/ Humans
/ Mastectomy - adverse effects
/ Oncology
/ Patients
/ Postoperative Complications - epidemiology
/ Postoperative Complications - etiology
/ SARS-CoV-2 - isolation & purification
/ Severe acute respiratory syndrome coronavirus 2
/ Surgery
